Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population

[1]  S. Dooley,et al.  TGF‐β signalling and liver disease , 2016, The FEBS journal.

[2]  K. Ishiyama.  Immune pathophysiology of acquired aplastic anemia. , 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[3]  Q. Ning,et al.  TGF-β1 polymorphisms and familial aggregation of liver cancer in Guangxi, China. , 2015, Genetics and molecular research : GMR.

[4]  E. Katsanis,et al.  The complex pathophysiology of acquired aplastic anaemia , 2015, Clinical and experimental immunology.

[5]  F. Fang,et al.  Role of TGFB1 polymorphism in the development of metastatic brain tumors in non-small cell lung cancer patients. , 2015, Genetics and molecular research : GMR.

[6]  C. Dufour,et al.  The diagnosis and treatment of aplastic anemia: a review , 2015, International Journal of Hematology.

[7]  O. Yokosuka,et al.  Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers. , 2014, World journal of gastroenterology.

[8]  Michael G. Kharas,et al.  Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs , 2014, The Journal of experimental medicine.

[9]  S. Botros,et al.  Immunoregulatory cytokines gene polymorphisms in Egyptian patients affected with acquired aplastic anemia , 2013, Annals of Hematology.

[10]  E. Fuchs,et al.  The harmonies played by TGF-β in stem cell biology. , 2012, Cell stem cell.

[11]  J. Maciejewski,et al.  Impact of immunogenetic polymorphisms in bone marrow failure syndromes. , 2011, Mini reviews in medicinal chemistry.

[12]  B. Kim,et al.  Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia , 2011, Annals of Hematology.

[13]  Z. Han,et al.  Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. , 2010, Critical reviews in oncology/hematology.

[14]  J. Cavenagh,et al.  Guidelines for the diagnosis and management of aplastic anaemia , 2009, British journal of haematology.

[15]  R. Flavell,et al.  TGF-β: A Master of All T Cell Trades , 2008, Cell.

[16]  K. Welte,et al.  [Congenital bone marrow failure syndromes. The last 20 years by the example of congenital neutropenia]. , 2007, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[17]  C. Zeidler,et al.  Angeborene Störungen der Blutbildung , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[18]  Chaeyoung Lee,et al.  The Gene Encoding Transforming Growth Factor &bgr;1 Confers Risk of Ischemic Stroke and Vascular Dementia , 2006, Stroke.

[19]  A. Iwama,et al.  Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells , 2006, The EMBO journal.

[20]  Y. Wan,et al.  Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.

[21]  R Weiskirchen,et al.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets , 2006, Journal of cellular and molecular medicine.

[22]  K. Bhoola,et al.  Genealogy, expression, and cellular function of transforming growth factor-beta. , 2003, Pharmacology & therapeutics.

[23]  M. Wadhwa,et al.  Reduced TGF‐β1 in patients with aplastic anaemia in vivo and in vitro , 1999, British journal of haematology.

[24]  M. Sporn,et al.  Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth , 1986, The Journal of experimental medicine.

[25]  R. Flavell,et al.  Transforming growth factor-β in T-cell biology , 2002, Nature Reviews Immunology.